BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14621606)

  • 1. [Therapeutic effect of gastrozolum in stomach ulcers].
    Sukhareva GV; Tsaregorodtseva TM; Trubitsina IE; Serova TI; Goncharenko LS; Dolgova NIu; Zarudnaia SI; Kuz'mina OS; Lopatina IN; Manannikov IV; Melik-Ogandzhanian NB
    Eksp Klin Gastroenterol; 2003; (5):25-30, 192. PubMed ID: 14621606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
    Arakawa T
    Nihon Rinsho; 1992 Jan; 50(1):122-30. PubMed ID: 1347325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
    Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase.
    Beil W; Sewing KF; Busche R; Wagner S
    Gut; 2001 Feb; 48(2):157-62. PubMed ID: 11156634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in the ultrastructure of the stomach mucous membrane parietal cells caused by inhibitors of hydrochloric acid secretion].
    Dondukova GV; Morozov IA
    Arkh Patol; 2002; 64(3):16-20. PubMed ID: 15338718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors.
    Katelaris PH
    Med J Aust; 1998 Aug; 169(4):208-11. PubMed ID: 9734580
    [No Abstract]   [Full Text] [Related]  

  • 7. Acid secretion and Helicobacter pylori.
    Sachs G; Meyer-Rosberg K; Scott DR; Melchers K; Shin J; Besancon M
    Digestion; 1997; 58 Suppl 1():8-13. PubMed ID: 9225081
    [No Abstract]   [Full Text] [Related]  

  • 8. Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.
    Hunt RH
    J Gastroenterol; 1994 Jul; 29 Suppl 7():128-33. PubMed ID: 7921145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of proton pump inhibitors in the treatment of Holicobacter pylori-associated ulcers].
    Huang J; Lu X; Hunt RH
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):488-91. PubMed ID: 10436949
    [No Abstract]   [Full Text] [Related]  

  • 10. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
    Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
    Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
    Boixeda D; Martín De Argila C; Bermejo F; López Sanromán A; Hernández Ranz F; García Plaza A
    Rev Esp Enferm Dig; 2003 Mar; 95(3):206-9, 202-5. PubMed ID: 12760710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of Lansoprazole (new proton pump inhibitor) against Helicobacter pylori and its therapeutic efficacy].
    Tamura K; Murai M; Tanaka M; Kawano S
    Nihon Rinsho; 1993 Dec; 51(12):3261-6. PubMed ID: 8283644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric acid secretion: activation and inhibition.
    Sachs G; Prinz C; Loo D; Bamberg K; Besancon M; Shin JM
    Yale J Biol Med; 1994; 67(3-4):81-95. PubMed ID: 7502535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
    Gabryelewicz A; Laszewicz W; Dzieniszewski J; Ciok J; Marlicz K; Bielecki D; Popiela T; Legutko J; Knapik Z; Poniewierka E
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():93-105. PubMed ID: 9440060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
    Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic features of proton pump inhibitors in the inhibition of gastric acid secretion: long-acting and complete inhibition].
    Ohe K
    Nihon Rinsho; 1992 Jan; 50(1):45-52. PubMed ID: 1311789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.
    Labenz J; Rühl GH; Bertrams J; Börsch G
    Am J Gastroenterol; 1994 May; 89(5):726-30. PubMed ID: 8172146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.